Logo image of ATA.PA

ATARI SA (ATA.PA) Stock Fundamental Analysis

EPA:ATA - Euronext Paris - Matif - FR0010478248 - Common Stock

0.1448  0 (-2.88%)

Fundamental Rating

1

Overall ATA gets a fundamental rating of 1 out of 10. We evaluated ATA against 45 industry peers in the Entertainment industry. Both the profitability and financial health of ATA have multiple concerns. ATA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ATA has reported negative net income.
ATA.PA Yearly Net Income VS EBIT VS OCF VS FCFATA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 5M -5M -10M

1.2 Ratios

Industry RankSector Rank
ROA -34.59%
ROE N/A
ROIC -13.78%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ATA.PA Yearly ROA, ROE, ROICATA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 50 100

1.3 Margins

Industry RankSector Rank
OM -29.82%
PM (TTM) -80.7%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ATA.PA Yearly Profit, Operating, Gross MarginsATA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 50 -50

More info and screens

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ATA is destroying value.
ATA has more shares outstanding than it did 1 year ago.
ATA has a better debt/assets ratio than last year.
ATA.PA Yearly Shares OutstandingATA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M
ATA.PA Yearly Total Debt VS Total AssetsATA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M

2.2 Solvency

ATA has an Altman-Z score of 1.45. This is a bad value and indicates that ATA is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of 0.11 indicates that ATA is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z 1.45
ROIC/WACC-1.41
WACC9.8%
ATA.PA Yearly LT Debt VS Equity VS FCFATA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 0.75 indicates that ATA may have some problems paying its short term obligations.
A Quick Ratio of 0.62 indicates that ATA may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.62
ATA.PA Yearly Current Assets VS Current LiabilitesATA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 5M 10M 15M

More info and screens

2

3. Growth

3.1 Past

ATA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -2177.42%.
ATA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -18.96%.
ATA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.69% yearly.
EPS 1Y (TTM)-2177.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-104.82%
Revenue 1Y (TTM)-18.96%
Revenue growth 3Y1.64%
Revenue growth 5Y9.69%
Sales Q2Q%-23.08%

3.2 Future

The Earnings Per Share is expected to decrease by -0.15% on average over the next years.
Based on estimates for the next years, ATA will show a small growth in Revenue. The Revenue will grow by 1.74% on average per year.
EPS Next Y0%
EPS Next 2Y2.54%
EPS Next 3Y0%
EPS Next 5Y-0.15%
Revenue Next Year-32.02%
Revenue Next 2Y-10.17%
Revenue Next 3Y-4.75%
Revenue Next 5Y1.74%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ATA.PA Yearly Revenue VS EstimatesATA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
ATA.PA Yearly EPS VS EstimatesATA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0 0.01 0.01 0.01

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ATA. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 14.34, which indicates a correct valuation of ATA.
The average S&P500 Price/Forward Earnings ratio is at 21.60. ATA is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 14.34
ATA.PA Price Earnings VS Forward Price EarningsATA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -191.64
ATA.PA Per share dataATA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.54%
EPS Next 3Y0%

More info and screens

0

5. Dividend

5.1 Amount

ATA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ATARI SA

EPA:ATA (6/29/2022, 7:00:00 PM)

0.1448

0 (-2.88%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap55.39M
Analysts80
Price Target0.68 (369.61%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.34
P/S 3.24
P/FCF N/A
P/OCF N/A
P/B 2.32
P/tB N/A
EV/EBITDA -191.64
EPS(TTM)-0.04
EYN/A
EPS(NY)0.01
Fwd EY6.98%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.04
BVpS0.06
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -34.59%
ROE N/A
ROCE N/A
ROIC -13.78%
ROICexc N/A
ROICexgc -23.14%
OM -29.82%
PM (TTM) -80.7%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.75
Quick Ratio 0.62
Altman-Z 1.45
F-Score2
WACC9.8%
ROIC/WACC-1.41
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2177.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-104.82%
EPS Next Y0%
EPS Next 2Y2.54%
EPS Next 3Y0%
EPS Next 5Y-0.15%
Revenue 1Y (TTM)-18.96%
Revenue growth 3Y1.64%
Revenue growth 5Y9.69%
Sales Q2Q%-23.08%
Revenue Next Year-32.02%
Revenue Next 2Y-10.17%
Revenue Next 3Y-4.75%
Revenue Next 5Y1.74%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A